Expression of Cytokines (TNF-α, IL-1α, and IL-2) in Chronic Hepatitis C: Comparative Hybridocytochemical and Immunocytochemical Study in Children and Adult Patients

Journal of Histochemistry and Cytochemistry

Volumn 52, Issue 1, 2004, Pages 29-38

  Kasprzak, Aldona ^a   Zabel, Maciej ^a,b   Biczysko, Wiesława ^a   Wysocki, Jacek ^a   Adamek, Agnieszka ^c   Spachacz, Rafał ^a   Surdyk Zasada, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c J Strus Hospital   (Poland)

Author keywords

Adult patients; Children; Chronic hepatitis C; Grading; IL 1 ; IL 2; Immunocytochemistry; ImmunoMax technique; In situ hybridization; Staging; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CELL; LIVER SINUSOID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; VIRUS TRANSFORMATION;

ALPHAVIRUS; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0346157392     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540405200104     Document Type: Article

References (31)

1. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, et al. (1997) Different cytokine profile of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infection. Gastroenterology 112:193-199
2. Beutler B, Cerami A (1989) The biology of cachectin/FNF-α primary mediator of the host response. Annu Rev Immunol 7:625-655
3. Dumoulin FL, Bach A, Leifeld L, El-Bakri M, Fischer HP, Sauerbruch T, Spengler U (1997) Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis 175:681-685
4. Dumoulin FL, Leifeld L, Honecker U, Sauerbruch T, Spengler U (1999) Intrahepatic expression of interleukin-1β and tumor necrosis factor-α in chronic hepatitis C. J Infect Dis 180:1704-1708
5. Eckels DD, Tabatabail N, Bian T-H, Wang H, Muheisen SS, Rice CM, Yoshizawa K, et al. (1999) In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: Failure in IL-2 production despite proliferation. Hum Immunol 60:187-199
6. Gonzalez-Amaro R, Garcia-Monzon G, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yague E, Pivel JP, et al. (1994) Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 179:841-848
7. Hoffmann R, Grewe M, Hans-Christoph Estler, Schulze-Specing A, Decker K (1994) Regulation of tumor necrosis factor-α-mRNA synthesis and distribution of tumor necrosis factor-α-mRNA synthesizing cells in rat liver during experimental endotoxemia. J Hepatol 20:122-128
8. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577-580
9. Kasprzak A, Zabel M, Wysocki J, Seidel J, Surdyk-Zasada J, Filipiak B (2002) Expression of mRNA for cytokines (TNF-α and IL-1α) in human cytomegalovirus (HCMV) and hepatitis B (HBV) infections. Folia Histochem Cytochem 40:63-68
10. Kinnman N, Andersson U, Hultcrantz R (2000) In situ expression of transforming growth factor-beta 1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C. Scand J Gastroenterol 35:1294-1300
11. Komminoth P, Werner M (1997) Target and signal amplification: approaches to increase the sensitivity of in situ hybridization. Histochem Cell Biol 108:325-333
12. Koziel MJ (1999) Cytokines in viral hepatitis. Semin Liver Dis 19:157-169
13. Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for complex physiology of TNF. Cell 53:45-53
14. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J (1996) Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology 23:210-217
15. Management of hepatitis C (1997) NIH Consensus Statement 15:1-41
16. McCaughan GW, Gorrell MD, Bishop GA, Abbott CA, Shackel NA, McGuinness PH, Levy MT et al. (2000) Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 174:172-191
17. McGuinness PH, Painter D, Davies S, McCaughan GW (2000) Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46:260-269
18. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759-765
19. Neuman MG, Benhamou JP, Bourliere M, Ibrahim A, Malkiewicz I, Asselah T, Martinot-Peignoux M, et al. (2002) Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine 17:108-117
20. Oyanagi Y, Takahashi T, Matsui S, Takahashi S, Boku S, Takahashi K, Furukawa K, et al. (1999) Enhanced expression of interleukin-6 in chronic hepatitis C. Liver 19:464-472
21. Peters M (1996) Action of cytokines on the immune response and viral interactions: an overview. Hepatology 23:911-916
22. Reichert TE, Watkins S, Stanson J, Johnson JT, Whiteside TL (1998) Endogenous IL-2 in cancer cells: a marker of cellular proliferation. J Histochem Cytochem 46:603-612
23. Santis AG, Companero MR, Alonso JL, Sanchez-Madrid F (1992) Regulation of tumor necrosis factor (TNF)-alpha synthesis and TNF receptors expression in T lymphocyte through the CD2 activation pathway. Eur J Immunol 22:3155-3160
24. Scheuer PJ, Standish RA, Dhillon AP (2002) Scoring of chronic hepatitis. Clin Liver Dis 6:335-347
25. Shapiro S, Gerstein V, Elias N, Zuckerman E, Salman N, Lahat N (1998) MRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment. Clin Exp Immunol 114:55-60
26. Simpson KJ, Lukacs NW, Colletti L, Strieter RM, Kunkel SL (1997) Cytokines and the liver. J Hepatol 27:1120-1132
27. Smith KA (1984) Interleukin 2. Annu Rev Immunol 2:319-333
28. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C (1992) Serum levels of cytokine in chronic liver diseases. Gastroenterology 103:264-274
29. Tsukamoto H (1999) Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcoholism. Clin Exp Res 23:911-916
30. Winwood PJ, Arthur MJP (1993) Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 13:50-59
31. Zhu NL, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MMC (1998) Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72:3691-3697